Opportunistic screening for COPD among socially marginalized patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Opportunistic screening for COPD among socially marginalized patients. / Brünés, Nina; Lindstroem, Mette Bendtz; Ulrik, Charlotte Suppli; Andersen, Ove; Lisby, Marianne; Godtfredsen, Nina Skavlan; Hansen, Tina Leth; Pisinger, Charlotta; Graven, Vibeke; Marsaa, Kristoffer; Thomsen, Laura Hohwü.

I: BMC Pulmonary Medicine, Bind 24, Nr. 1, 113, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Brünés, N, Lindstroem, MB, Ulrik, CS, Andersen, O, Lisby, M, Godtfredsen, NS, Hansen, TL, Pisinger, C, Graven, V, Marsaa, K & Thomsen, LH 2024, 'Opportunistic screening for COPD among socially marginalized patients', BMC Pulmonary Medicine, bind 24, nr. 1, 113. https://doi.org/10.1186/s12890-024-02927-9

APA

Brünés, N., Lindstroem, M. B., Ulrik, C. S., Andersen, O., Lisby, M., Godtfredsen, N. S., Hansen, T. L., Pisinger, C., Graven, V., Marsaa, K., & Thomsen, L. H. (2024). Opportunistic screening for COPD among socially marginalized patients. BMC Pulmonary Medicine, 24(1), [113]. https://doi.org/10.1186/s12890-024-02927-9

Vancouver

Brünés N, Lindstroem MB, Ulrik CS, Andersen O, Lisby M, Godtfredsen NS o.a. Opportunistic screening for COPD among socially marginalized patients. BMC Pulmonary Medicine. 2024;24(1). 113. https://doi.org/10.1186/s12890-024-02927-9

Author

Brünés, Nina ; Lindstroem, Mette Bendtz ; Ulrik, Charlotte Suppli ; Andersen, Ove ; Lisby, Marianne ; Godtfredsen, Nina Skavlan ; Hansen, Tina Leth ; Pisinger, Charlotta ; Graven, Vibeke ; Marsaa, Kristoffer ; Thomsen, Laura Hohwü. / Opportunistic screening for COPD among socially marginalized patients. I: BMC Pulmonary Medicine. 2024 ; Bind 24, Nr. 1.

Bibtex

@article{4235eaad931a4fc9aa7cfcdb096c1f52,
title = "Opportunistic screening for COPD among socially marginalized patients",
abstract = "Background: Chronic obstructive pulmonary disease (COPD) is a common disease associated with premature death. Tobacco exposure is the main risk factor, but lower socioeconomic status, early life insults, and occupational exposures are also important risk factors. Socially marginalized people, facing homelessness, substance use disorder, and mental illness, are likely to have a higher risk of developing COPD, and, furthermore, experience barriers to healthcare access and consequently poorer outcomes. Objective: This study aims to assess COPD prevalence and the impact of opportunistic screening among hospitalized patients who are in contact with hospital social nurses. These patients constitute a group of patients with a high prevalence of psychiatric and somatic diseases, substance use, low life expectancy, and are socially marginalized. Methods: The present prospective longitudinal study includes a clinical examination at baseline. Participants will have spirometry done and be interviewed regarding risk factors, socioeconomic conditions, and respiratory symptoms. The 5-year follow-up assessment incorporates data from baseline and register data over the 5 years, including information on morbidity, use of COPD medication, hospital contacts, mortality, and socioeconomic factors. Anticipated results: Referral for further diagnostic work-up and management after the screening, including COPD treatment and smoking cessation support, is expected to improve survival rates. The study is still enrolling patients. Trial registration: The study is registered at ClinicalTrials.gov, NCT04754308 with study status: “enrolling”.",
keywords = "COPD, Equality in healthcare, Nursing, Screening",
author = "Nina Br{\"u}n{\'e}s and Lindstroem, {Mette Bendtz} and Ulrik, {Charlotte Suppli} and Ove Andersen and Marianne Lisby and Godtfredsen, {Nina Skavlan} and Hansen, {Tina Leth} and Charlotta Pisinger and Vibeke Graven and Kristoffer Marsaa and Thomsen, {Laura Hohw{\"u}}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",
year = "2024",
doi = "10.1186/s12890-024-02927-9",
language = "English",
volume = "24",
journal = "B M C Pulmonary Medicine",
issn = "1471-2466",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Opportunistic screening for COPD among socially marginalized patients

AU - Brünés, Nina

AU - Lindstroem, Mette Bendtz

AU - Ulrik, Charlotte Suppli

AU - Andersen, Ove

AU - Lisby, Marianne

AU - Godtfredsen, Nina Skavlan

AU - Hansen, Tina Leth

AU - Pisinger, Charlotta

AU - Graven, Vibeke

AU - Marsaa, Kristoffer

AU - Thomsen, Laura Hohwü

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024

Y1 - 2024

N2 - Background: Chronic obstructive pulmonary disease (COPD) is a common disease associated with premature death. Tobacco exposure is the main risk factor, but lower socioeconomic status, early life insults, and occupational exposures are also important risk factors. Socially marginalized people, facing homelessness, substance use disorder, and mental illness, are likely to have a higher risk of developing COPD, and, furthermore, experience barriers to healthcare access and consequently poorer outcomes. Objective: This study aims to assess COPD prevalence and the impact of opportunistic screening among hospitalized patients who are in contact with hospital social nurses. These patients constitute a group of patients with a high prevalence of psychiatric and somatic diseases, substance use, low life expectancy, and are socially marginalized. Methods: The present prospective longitudinal study includes a clinical examination at baseline. Participants will have spirometry done and be interviewed regarding risk factors, socioeconomic conditions, and respiratory symptoms. The 5-year follow-up assessment incorporates data from baseline and register data over the 5 years, including information on morbidity, use of COPD medication, hospital contacts, mortality, and socioeconomic factors. Anticipated results: Referral for further diagnostic work-up and management after the screening, including COPD treatment and smoking cessation support, is expected to improve survival rates. The study is still enrolling patients. Trial registration: The study is registered at ClinicalTrials.gov, NCT04754308 with study status: “enrolling”.

AB - Background: Chronic obstructive pulmonary disease (COPD) is a common disease associated with premature death. Tobacco exposure is the main risk factor, but lower socioeconomic status, early life insults, and occupational exposures are also important risk factors. Socially marginalized people, facing homelessness, substance use disorder, and mental illness, are likely to have a higher risk of developing COPD, and, furthermore, experience barriers to healthcare access and consequently poorer outcomes. Objective: This study aims to assess COPD prevalence and the impact of opportunistic screening among hospitalized patients who are in contact with hospital social nurses. These patients constitute a group of patients with a high prevalence of psychiatric and somatic diseases, substance use, low life expectancy, and are socially marginalized. Methods: The present prospective longitudinal study includes a clinical examination at baseline. Participants will have spirometry done and be interviewed regarding risk factors, socioeconomic conditions, and respiratory symptoms. The 5-year follow-up assessment incorporates data from baseline and register data over the 5 years, including information on morbidity, use of COPD medication, hospital contacts, mortality, and socioeconomic factors. Anticipated results: Referral for further diagnostic work-up and management after the screening, including COPD treatment and smoking cessation support, is expected to improve survival rates. The study is still enrolling patients. Trial registration: The study is registered at ClinicalTrials.gov, NCT04754308 with study status: “enrolling”.

KW - COPD

KW - Equality in healthcare

KW - Nursing

KW - Screening

U2 - 10.1186/s12890-024-02927-9

DO - 10.1186/s12890-024-02927-9

M3 - Journal article

C2 - 38443835

AN - SCOPUS:85186890746

VL - 24

JO - B M C Pulmonary Medicine

JF - B M C Pulmonary Medicine

SN - 1471-2466

IS - 1

M1 - 113

ER -

ID: 385686849